{
    "id": 30330,
    "fullName": "MAGEA4 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "MAGEA4 positive indicates the presence of the MAGEA4 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 4103,
        "geneSymbol": "MAGEA4",
        "terms": [
            "MAGEA4",
            "CT1.4",
            "MAGE-41",
            "MAGE-X2",
            "MAGE4",
            "MAGE4A",
            "MAGE4B"
        ]
    },
    "variant": "positive",
    "createDate": "06/13/2019",
    "updateDate": "06/13/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20767,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, ADP-A2M4 cells induced cytoxicity against MAGE-A4 positive melanoma cells in culture, and inhibited tumor growth, induced regression, and resulted in a 100% survival in cell line xenograft models (PMID: 32002290).",
            "molecularProfile": {
                "id": 32487,
                "profileName": "MAGEA4 positive"
            },
            "therapy": {
                "id": 7280,
                "therapyName": "ADP-A2M4 cells",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 18034,
                    "pubMedId": 32002290,
                    "title": "Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/32002290"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 21038,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, treatment with ADP-A2M4CD8 cells resulted in increased killing of MAGE-A4-positive tumor cells in culture (Cancer Res 2019;79(13 Suppl):Abstract nr 2313).",
            "molecularProfile": {
                "id": 32487,
                "profileName": "MAGEA4 positive"
            },
            "therapy": {
                "id": 9445,
                "therapyName": "ADP-A2M4CD8 cells",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 18036,
                    "pubMedId": null,
                    "title": "Enhanced activity of second-generation MAGE-A4 SPEAR T-cells through co-expression of a CD8alpha homodimer",
                    "url": "https://cancerres.aacrjournals.org/content/79/13_Supplement/2313"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 32487,
            "profileName": "MAGEA4 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}